A XM não fornece serviços a residentes nos Estados Unidos da América.
G
G

GlobalPayments


Notícias

U.S. Amphastar Pharmaceuticals, G1 Therapeutics, Upwork

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, G1 Therapeutics, Upwork Aug 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amphastar Pharmaceuticals, G1 Therapeutics and Upwork on Thursday. HIGHLIGHTS * Amphastar Pharmaceuticals Inc AMPH.O : Piper Sandler cuts target price to $66 from $71 * Charles River Laboratories International Inc CRL.N : Baird cuts to neutral * G1 Therapeutics Inc GTHX.O : H.C.
A
A
C
G
A
C
I

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Fortinet Inc FTNT.OQ +26.2% Axon Enterprise Inc AXON.OQ +18.5% Global Payments Inc GPN.N +7.3% Devon Energy Corp DVN.N +3.9% Henry Schein Inc HSIC.OQ +3.8% Bottom Performers Percent Change Super Micro Computer Inc SMCI.OQ -19.8% Airbnb
F
U
D
G

Global Payments Inc reports results for the quarter ended in June - Earnings Summary

Global Payments Inc reports results for the quarter ended in June - Earnings Summary Global Payments Inc GPN.N reported quarterly adjusted earnings of $2.93​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $2.62. The mean expectation of thirty analysts for the quarter was for earnings of $2.90 per share.
G

U.S. STOCKS Ralph Lauren, Illumina, Disney

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, and cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
C
F
I
T
U
G
L
S
A

Global Payments beats Q2 profit estimates as consumers shrug off slowdown fears

REFILE-Global Payments beats Q2 profit estimates as consumers shrug off slowdown fears Corrects headline to fix syntax error in company name Aug 7 (Reuters) - Payment company Global Payments GPN.N beat profit estimates for second quarter on Wednesday, as consumer spending remains resilient despite worries about a economic slowdown. WHY IT'S IMPORTANT Despite recent economic data fueling recession fears, American consumers have remained resilient in face of higher-for-longer interest rates.
V
G

Global Payments up after Q2 profit beat

BUZZ-Global Payments up after Q2 profit beat ** Shares of payment technology company Global Payments GPN.N up 7.6% at $100.10 in premarket ** Co beats second quarter adjusted profit estimates helped by strong consumer spending ** GPN posts adjusted profit of $2.93 per share in the three months ended June 30, above analysts' estimates of $2.90 - LSE
G

Global Payments Q2 Adjusted EPS USD 2.93 Vs. IBES Estimate USD 2.9

BRIEF-Global Payments Q2 Adjusted EPS USD 2.93 Vs. IBES Estimate USD 2.9 Aug 07 (Reuters) - Global Payments Q2 revenue USD 2,570 million. Q2 adjusted revenue USD 2,320 million vs. IBES estimate USD 2,317 million Q2 EPS USD 1.47 outlook FY adjusted EPS USD 11.54-11.7 outlook FY adjusted revenue USD 9,170-9,300 million
G

Global Payments Inc <GPN.N> expected to post earnings of $2.90 a share - Earnings Preview

Global Payments Inc expected to post earnings of $2.90 a share - Earnings Preview Global Payments Inc GPN.N , GPN is expected to show a rise in quarterly revenue when it reports results on August 7 for the period ending June 30 2024 The Atlanta Georgia-based company is expected to report a 5.2% increase in revenue to $2.316 billion from $2.2 billion a year ago, according to the mean estimate from 27 analysts, based on LSEG data.
G

U.S. Appfolio, J B Hunt Transport Services, UnitedHealth Group

U.S. RESEARCH ROUNDUP-Appfolio, J B Hunt Transport Services, UnitedHealth Group July 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Appfolio, J B Hunt Transport Services and UnitedHealth Group, on Wednesday. HIGHLIGHTS * Appfolio Inc APPF.O : JP Morgan raises target price to $328 from $260 * J B Hunt Transport Services Inc JBHT.O : JP Morgan raises PT to $201 from $184 * Norfolk Southern Corp NSC.N : Jefferies cu
A
A
C
C
G
J
A
J
U
G
C

U.S. Acelyrin, Blue Owl Capital, Malibu Boats

U.S. RESEARCH ROUNDUP-Acelyrin, Blue Owl Capital, Malibu Boats July 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acelyrin, Blue Owl Capital and Malibu Boats, on Monday. HIGHLIGHTS * Acelyrin Inc SLRN.O : Wells Fargo raises to overweight from equal-weight * Blue Owl Capital Inc OWL.N : TD Cowen cuts to hold from buy * J B Hunt Transport Services Inc JBHT.O : Stephens initiates with overweight rating * Malibu Boat
A
A
C
C
G
G
U
G
A
A
A
A
R

U.S. CME Group, Ingersoll Rand, Winnebago Industries

U.S. RESEARCH ROUNDUP-CME Group, Ingersoll Rand, Winnebago Industries June 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CME Group, Ingersoll Rand and Winnebago Industries, on Friday. HIGHLIGHTS * CME Group Inc CME.O : JP Morgan cuts to underweight from neutral * Ingersoll Rand Inc IR.N : Jefferies resumes coverage with buy rating; PT $110 * Nike Inc NKE.N : Oppenheimer raises to outperform from perform * Sarept
A
A
C
K
M
M
N
N
G
I
A
D

U.S. BioNTech, Honeywell International, Klaviyo

U.S. RESEARCH ROUNDUP-BioNTech, Honeywell International, Klaviyo June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday. HIGHLIGHTS * BioNTech SE BNTX.O : JP Morgan raises target price to $94 from $90 * Honeywell International Inc HON.O : HSBC raises target price to $235 from $200 * Klaviyo Inc KVYO.N : Barclays raises to overweight from equal weight * NetA
A
F
G
N
R
G
D
M

U.S. STOCKS MakeMyTrip, WaFd, Bolt Biotherapeutics

BUZZ-U.S. STOCKS ON THE MOVE-MakeMyTrip, WaFd, Bolt Biotherapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The benchmark S&P 500 .SPXand the Nasdaq .IXIC touchedrecord highs on Wednesday after a lower-than-expected increase in a key inflation metric buttressed hopes that the Federal Reserve will cut interest rates this year.
B
C
G
U
U
D
G

Global Payments dips after Mizuho cuts PT

BUZZ-Global Payments dips after Mizuho cuts PT ** Shares of payments technology firm Global Payments GPN.N fall as much as 1.8%, last down 1.1% at $108.95 ** Mizuho Securities cuts GPN PT to $105 from $129, a 4.7% downside to the last close; reiterates "neutral" rating on the stock ** Brokerage says GPN shares have underperformed this year largely
G



Condições

Ativos populares

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.